Mohamed Saleh
Post-Doctoral Fellow
Last active: 12/21/2015


None provided


The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. DC isoketal-modified proteins activate T cells and promote hypertension. Kirabo A, Fontana V, de Faria AP, Loperena R, Galindo CL, Wu J, Bikineyeva AT, Dikalov S, Xiao L, Chen W, Saleh MA, Trott DW, Itani HA, Vinh A, Amarnath V, Amarnath K, Guzik TJ, Bernstein KE, Shen XZ, Shyr Y, Chen SC, Mernaugh RL, Laffer CL, Elijovich F, Davies SS, Moreno H, Madhur MS, Roberts J, Harrison DG (2014) J Clin Invest 124(10): 4642-56
    › Primary publication · 25244096 (PubMed) · PMC4220659 (PubMed Central)
  2. TFF1 activates p53 through down-regulation of miR-504 in gastric cancer. Soutto M, Chen Z, Saleh MA, Katsha A, Zhu S, Zaika A, Belkhiri A, El-Rifai W (2014) Oncotarget 5(14): 5663-73
    › Primary publication · 25015107 (PubMed) · PMC4170596 (PubMed Central)
  3. Inflammation and mechanical stretch promote aortic stiffening in hypertension through activation of p38 mitogen-activated protein kinase. Wu J, Thabet SR, Kirabo A, Trott DW, Saleh MA, Xiao L, Madhur MS, Chen W, Harrison DG (2014) Circ Res 114(4): 616-25
    › Primary publication · 24347665 (PubMed) · PMC4186716 (PubMed Central)
  4. CXCL16: a chemokine-causing chronic kidney disease. Norlander AE, Saleh MA, Madhur MS (2013) Hypertension 62(6): 1008-10
    › Primary publication · 24060889 (PubMed) · PMC3970762 (PubMed Central)
  5. Chronic endothelin-1 infusion elevates glomerular sieving coefficient and proximal tubular albumin reuptake in the rat. Saleh MA, Sandoval RM, Rhodes GJ, Campos-Bilderback SB, Molitoris BA, Pollock DM (2012) Life Sci 91(13-14): 634-7
    › Primary publication · 22727794 (PubMed) · PMC3728660 (PubMed Central)
  6. Induction of hemeoxygenase-1 reduces glomerular injury and apoptosis in diabetic spontaneously hypertensive rats. Elmarakby AA, Faulkner J, Baban B, Saleh MA, Sullivan JC (2012) Am J Physiol Renal Physiol 302(7): F791-800
    › Primary publication · 22205229 (PubMed) · PMC3340931 (PubMed Central)
  7. Endothelin in renal inflammation and hypertension. Saleh MA, Pollock DM (2011) Contrib Nephrol : 160-170
    › Primary publication · 21893997 (PubMed)
  8. Distinct actions of endothelin A-selective versus combined endothelin A/B receptor antagonists in early diabetic kidney disease. Saleh MA, Pollock JS, Pollock DM (2011) J Pharmacol Exp Ther 338(1): 263-70
    › Primary publication · 21471190 (PubMed) · PMC3126640 (PubMed Central)
  9. Endothelin receptor A-specific stimulation of glomerular inflammation and injury in a streptozotocin-induced rat model of diabetes. Saleh MA, Boesen EI, Pollock JS, Savin VJ, Pollock DM (2011) Diabetologia 54(4): 979-88
    › Primary publication · 21191784 (PubMed) · PMC3804244 (PubMed Central)
  10. Endothelin-1 increases glomerular permeability and inflammation independent of blood pressure in the rat. Saleh MA, Boesen EI, Pollock JS, Savin VJ, Pollock DM (2010) Hypertension 56(5): 942-9
    › Primary publication · 20823379 (PubMed) · PMC2959121 (PubMed Central)
  11. O-GlcNAcylation contributes to augmented vascular reactivity induced by endothelin 1. Lima VV, Giachini FR, Carneiro FS, Carneiro ZN, Saleh MA, Pollock DM, Fortes ZB, Carvalho MH, Ergul A, Webb RC, Tostes RC (2010) Hypertension 55(1): 180-8
    › Primary publication · 19948983 (PubMed) · PMC2808689 (PubMed Central)
  12. Interleukin-1beta, but not interleukin-6, enhances renal and systemic endothelin production in vivo. Boesen EI, Sasser JM, Saleh MA, Potter WA, Woods M, Warner TD, Pollock JS, Pollock DM (2008) Am J Physiol Renal Physiol 295(2): F446-53
    › Primary publication · 18524861 (PubMed) · PMC2519182 (PubMed Central)